You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

Details for Patent: 12,042,494


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 12,042,494 protect, and when does it expire?

Patent 12,042,494 protects AKYNZEO and is included in one NDA.

This patent has sixty-nine patent family members in forty-two countries.

Summary for Patent: 12,042,494
Title:Compositions and methods for treating centrally mediated nausea and vomiting
Abstract:Provided are compositions and methods for treating or preventing nausea and vomiting in patients undergoing chemotherapy, radiotherapy, or surgery.
Inventor(s):Fabio Trento, Sergio Cantoreggi, Giorgia Rossi, Roberta Cannella, Daniele Bonadeo
Assignee:Helsinn Healthcare SA
Application Number:US18/082,737
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 12,042,494: A Detailed Analysis

Introduction

When analyzing a patent, particularly one like United States Patent 12,042,494, it is crucial to delve into its scope, claims, and the broader patent landscape. This analysis helps innovators, patent practitioners, and business professionals make informed decisions about the patent's validity, potential for infringement, and strategic positioning within the market.

Patent Scope and Claims

To begin with, let's focus on the scope and claims of the patent in question.

Subject Matter Eligibility

The 2024 USPTO guidance update on AI patents provides valuable insights into how subject matter eligibility is determined. For a patent like 12,042,494, the claims must integrate judicial exceptions into practical applications to be considered patent-eligible. This involves assessing whether the claims impose meaningful limits on the exception, transforming the abstract idea into patent-eligible subject matter[1].

For example, if the patent claims involve AI-related inventions, the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring it offers a concrete technological improvement[1].

Claim Construction

The claims of the patent need to be carefully constructed to avoid common pitfalls such as being deemed too abstract or lacking a practical application. The "Alice" test, a two-step framework developed by the Supreme Court, is often used to determine patent eligibility. At Alice step one, the court considers whether the claims are directed to an abstract idea. If so, the inquiry proceeds to Alice step two, where it is determined whether the claims recite something "significantly more" than the abstract idea itself[2].

Practical Applications and Technological Improvements

To ensure patent eligibility, the claims must specify practical applications that provide tangible benefits. For instance, if a claim involves the use of AI in a speech recognition system to enhance the accuracy of voice commands in hands-free environments, it must demonstrate how this application improves technology or solves specific problems in the relevant field[1].

Patent Landscape Analysis

A comprehensive patent landscape analysis is essential for understanding the broader context in which the patent operates.

Geographical Spread and Saturation

Analyzing the geographical spread of a technology patent area helps in identifying key markets and the level of saturation. This is crucial for determining the potential rewards or perils of entering a particular technology space. For example, if the patent area is highly saturated, it may be challenging to secure claims, and alternative technologies might need to be explored[3].

Competitors and New Entrants

Identifying competitors and new entrants in the patent space provides strategic insights. A patent landscape analysis can reveal which companies are actively innovating in the area, their focus, and the trends over time. This information can guide decisions on whether to continue research and development in a particular area or to pivot to newer inventive spaces[3].

Time-Slicing and Trend Analysis

Time-slicing, or analyzing patent activity over different time periods, can highlight trends and shifts in the technology area. This approach can show whether certain technologies are being abandoned or if new areas are gaining traction. For instance, if a company's patent portfolio shows a significant decrease in activity in a particular technology area over the years, it may indicate a shift in focus or the abandonment of that technology[3].

Strategic Insights from Patent Landscape Analysis

A thorough patent landscape analysis can uncover strategic insights that might otherwise be missed.

Identifying Niche Areas

By analyzing the patent landscape, one can identify underappreciated niche areas that offer opportunities for innovation. For example, if a company has a significant portion of its patent portfolio focused on a specific niche technology, it may indicate a strategic focus area that competitors could leverage or challenge[3].

Decision-Making for R&D and IP

The results of a patent landscape analysis can guide long-term decisions about research and development. If a technology area is highly saturated, it may be wise to pivot to newer inventive spaces to avoid the challenges of securing claims in a crowded field. This approach helps in making informed decisions about where to allocate resources and how to position the company within the competitive landscape[3].

Key Takeaways

  • Subject Matter Eligibility: Ensure that patent claims integrate judicial exceptions into practical applications to meet the criteria for patent eligibility.
  • Practical Applications: Highlight real-world applications of the claimed method or system to demonstrate tangible benefits and technological improvements.
  • Patent Landscape Analysis: Conduct a comprehensive analysis to understand the geographical spread, saturation, competitors, and trends in the technology area.
  • Strategic Decision-Making: Use patent landscape analysis to guide R&D and IP decisions, identifying opportunities in niche areas and avoiding highly saturated fields.

FAQs

Q: How does the 2024 USPTO guidance update impact AI-related patent claims? A: The update refines the process for determining the patent eligibility of AI-related inventions, focusing on whether claims integrate judicial exceptions into practical applications and provide meaningful limits on the exception.

Q: What is the significance of the "Alice" test in determining patent eligibility? A: The "Alice" test is a two-step framework that determines whether claims are directed to an abstract idea and if they recite something "significantly more" than the abstract idea itself.

Q: Why is patent landscape analysis important for innovators and IP professionals? A: It provides strategic insights into the competitive landscape, helping to identify opportunities, avoid saturated fields, and make informed decisions about R&D and IP strategies.

Q: How can time-slicing in patent landscape analysis be beneficial? A: Time-slicing helps in identifying trends and shifts in technology areas over time, indicating whether certain technologies are being abandoned or if new areas are gaining traction.

Q: What are the implications of a highly saturated patent space for new entrants? A: A highly saturated patent space can make it challenging to secure claims, prompting new entrants to explore alternative technologies or niche areas to avoid competition.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. CONTOUR IP HOLDING LLC v. GOPRO, INC. - United States Court of Appeals for the Federal Circuit
  3. Patent Landscape Analysis - Uncovering Strategic Insights - AcclaimIP
  4. Invention, Knowledge Transfer, and Innovation - National Science Foundation
  5. 35 USC 282: Presumption of validity; defenses - U.S. House of Representatives

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 12,042,494

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Helsinn Hlthcare AKYNZEO netupitant; palonosetron hydrochloride CAPSULE;ORAL 205718-001 Oct 10, 2014 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y METHOD OF TREATING EMESIS ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

International Family Members for US Patent 12,042,494

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
African Regional IP Organization (ARIPO) 3083 ⤷  Try for Free
Australia 2010320598 ⤷  Try for Free
Brazil 112012011485 ⤷  Try for Free
Canada 2778301 ⤷  Try for Free
Chile 2012001276 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.